Back to search

Article

Oral Belzutifan Treatment in von Hippel-Lindau-Associated Retinal Haemangioblastoma: A Promising Approach

2026-01-30

Abstract excerpt

<title>Abstract</title> <p>Objectives To assess the efficacy and safety of oral belzutifan in a real-world cohort of pretreated patients with von Hippel-Lindau (vHL)-associated retinal haemangioblastomas (RHs). Methods This retrospective observational study included genetically confirmed vHL patients with RHs, in whom at least one eye had been previously refractory to conventional ocular therapy. Patients recei...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7a38e51-0595-5e50-a91b-11118f1ce7f6
DOI
10.21203/rs.3.rs-8503671/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Oral Belzutifan Treatment in von Hippel-Lindau-Associated Retinal Haemangioblastoma: A Promising ApproachDOI 10.21203/rs.3.rs-8503671/v1
Select a neighboring publication to make it the new centre.